Futility analyses in clinical trials are designed for all the right reasons: we want to stop exposing subjects to unnecessary risk and inconvenience if there is no chance that the intervention will provide them with benefit, and we want to direct resources toward more promising treatments.

(1) R. Doody J Prev Alz Dis 2020;1(7):7

Article R. Doody